About Jeffrey Barnes, MD, PhD
Jeffrey Barnes, MD, PhD is a graduate of the University of Illnois College of Medicine. He completed his residency in Internal Medicine at the Beth Israel Deaconess Medical Center in Boston. He then completed his fellowship in Medical Oncology at the Dana Farber Cancer Institute before joining the faculty at the Massachusetts General Hospital. He is a member of the US Cutaneous Lymphoma Consortium. His research interests focus on the identification and evaluation of novel agents for the treatment of lymphoma.
Departments, Centers, & Programs:
Clinical Interests:
- Chronic lymphocytic leukemia (CLL)
- Cutaneous b-cell lymphoma
- Cutaneous t-cell lymphoma
- Hodgkin's lymphoma (also known as Hodgkin's disease)
- Non-Hodgkin's lymphoma (NHL)
Treats:
- Adult
Locations
Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Fax: 617-726-8330
Martha's Vineyard Hospital
1 Hospital Rd.
Oak Bluffs, MA 02557
Phone: 508-693-0410
Mass General Cancer Center at Newton-Wellesley
2014 Washington St.
Newton, MA 02462
Phone: 617-219-1230
Medical Education
- , University of Illinois College of Medicine at Urbana-Champaign
- Fellowship, Dana Farber Cancer Institute
American Board Certifications
- Hematology, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Barnes performs translational research in lymphoma including clinical trials of novel therapies for the treatment of cutaneous lymphoma, non-Hodgkin lymphomas, Hodgkin lymphoma (Hodgkin's disease), and chronic lymphocytic leukemia.
Publications
-
Select Publications:
- Barnes JA, Abramson JS. Differential Diagnosis and Novel Treatment Strategies for Adult T Cell Leukemia Lymphoma. Oncology. Dec 23;14, p.1267-1270 (2009)
- Abramson JS, Hellmann M, Barnes JA, Hammermann P, Toomey C, Takvorian T, Muzikansky A, Hochberg EP. Intravenous methotrexate as central nervous system prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma. Cancer Jun 8 Epub ahead of print (2010)
- Barnes JA, LaCasce AS, Zukotynski K, Israel D, Feng Y, Neuburg D, Tomey C, Hochberg EP, Canellos GP, Abramson JS. End of treatment but not interim PET scan predicts outcomes in non-bulky limited stage Hodgkin lymphoma. Ann of Oncology Oct 15 (2010)
- Barnes JA, LaCasce AS, Feng Y, Tomey C, Neuburg D, Michaelson JS, Hochberg EP, Abramson JS. Evaluation of the Addition of Rituximab to CODOX-M/IVAC for Burkitt Lymphoma: A Retrospective Analysis. Ann of Oncology In Feb 21 (2011)